NRBO - NeuroBo Pharmaceuticals, Inc. Sotuvning sof marjinal rentabelligi

NRBO (NeuroBo Pharmaceuticals, Inc.) - kompaniyaning tovar belgisi

Haqiqiy sof foyda marjalari patent monopoliyasi va dori vositalarini sintez qilishning past xarajatlari hisobiga NeuroBo Pharmaceuticals (NRBO) kompaniyasining kengayish salohiyatini namoyish etmoqda. Olimlarning ixcham jamoasi va Osiyo hamkorining qo'llab-quvvatlashi tadqiqot va ishlanmalar (R&D) yadrosining barqarorligini ta'minlaydi. DA-1726 sinovlari hamda MASH va semizlikga qarshi terapiyalarga bo'lgan yuqori talab fonida 0.00 darajasi yangi qiymatlarni qayd etmoqda.

NeuroBo Pharmaceuticals (NRBO) Sof foyda normasi: 04.07.2022 - 07.12.2024 davri uchun

NRBO (NeuroBo): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

Kompaniyaning asosiy tahlili:NeuroBo Pharma - NRBO
NeuroBo Pharmaceuticals Inc yetakchi tovari

NeuroBo Pharmaceuticals (NRBO) kompaniyasining investitsiya jozibadorligi uning metabolik buzilishlar terapiyasi salohiyatiga asoslangan. Ushbu ko'rsatkich jami daromadlarda sof foydaning ulushini belgilab, xarajatlarni boshqarishning yakuniy samaradorligini baholaydi. Sof marjani tahlil qilish daromadlilikning haqiqiy dinamikasini aniqlash uchun vaqtincha tebranishlarni filtrlash imkonini beradi. Ushbu semizlikka qarshi dori ishlab chiquvchi kompaniya uchun ushbu tendentsiya tadqiqot va ishlanmalar ( R&D ) xarajatlari hamda moliyaviy daromadlar o'rtasidagi muvozanatni aks ettiradi. Chiziqning barqaror o'sishi biznes modelining fundamental barqarorligini tasdiqlaydi.

Raqobatdosh kompaniyalar tahlili

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|NKGen Biotech, Inc. (NKGN) - Sof foyda bo'yicha sotuv rentabelligi|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel